For the quarter ending 2026-01-31, ALZN has $4,041,833 in assets. $1,857,328 in debts. $2,713,139 in cash and cash equivalents.
| Balance Sheets | 2026-01-31 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Cash | 2,713,139 | 4,449,433 | 5,620,872 | |
| Prepaid expenses and other current assets | 986,143 | 272,015 | 307,958 | |
| Total current assets | 3,699,282 | 4,721,448 | 5,928,830 | |
| Property and equipment, net | 342,551 | 370,236 | 397,921 | |
| Total assets | 4,041,833 | 5,091,684 | 6,326,751 | |
| Accounts payable and accrued liabilities | 1,857,328 | 717,488 | 983,311 | |
| Total liabilities, all current | 1,857,328 | 717,488 | 983,311 | |
| Preferred stock, value-Series BPreferred Stock | - | - | 0 | |
| Preferred stock, value-Series CPreferred Stock | - | - | 0 | |
| Common stock, 0.0001 par value 300,000,000 shares authorized 3,804,741 and 778,733 issued and outstanding as of january 31, 2026 and april 30, 2025, respectively | 380 | 380 | 314 | |
| Additional paid-in capital | 66,621,819 | 66,612,519 | 66,581,071 | |
| Accumulated deficit | -64,437,694 | -62,238,703 | -61,237,945 | |
| Total stockholders equity | 2,184,505 | 4,374,196 | 5,343,440 | |
| Total liabilities and stockholders equity | 4,041,833 | 5,091,684 | 6,326,751 | |
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)